Relationship between elevated serum Troponin values in end-stage renal disease patients and abnormal isotopic cardiac scans following stress

Renal Failure

Volumn 25, Issue 1, 2003, Pages 55-65

  Porter, George A ^a   Norton, Theadore L ^a   Lindsley, Jessie ^a   Stevens, Jeffrey S ^a   Phillips, David S ^a   Bennett, William M ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Legacy Transplant Services   (United States)

Author keywords

Cardiac markers; ESRD; Pre transplant evaluation; Stress testing; Troponins

Indexed keywords

BIOCHEMICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; DIPYRIDAMOLE; DOBUTAMINE; FRUCTOSE BISPHOSPHATE ALDOLASE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; THALLIUM 201; TROPONIN; TROPONIN I; TROPONIN T;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; EXERCISE TEST; FEMALE; GLOMERULONEPHRITIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART SCINTISCANNING; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; IMMUNOASSAY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PERITONEAL DIALYSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; BIOLOGICAL MARKERS; CREATINE KINASE; CREATINE KINASE, MB FORM; EXERCISE TEST; FEMALE; HEART VENTRICLES; HUMANS; ISOENZYMES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; OREGON; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; STATISTICS; TROPONIN;

EID: 0037286458     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120017468     Document Type: Article

References (41)

1. Ohman, E.M.; Armstrong, P.W.; Christenson, R.H.; Granger, C.B.; Katus, H.A.; Hamm, C.W.; O'Hanesian, M.A.; Wagner, G.S.; Kleiman, N.S.; Harrell, F.E.; Califf, R.M.; Topol, E.J. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N. Engl. J. Med. 1996, 335, 1333-1341.
2. Antman, E.M.; Tanasijevic, M.J.; Thompson, B.; Schactman, M.; McCabe, C.H.; Cannon, C.P.; Fischer, G.A.; Fung, A.Y.; Thompson, C.; Wybenga, D.; Braunwald, E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N. Engl. J. Med. 1996, 335, 1342-1349.
3. Dean, K.J. Cardiac troponin T as a marker of myocardial injury. In Pathology and Laboratory Medicine: Cardiac Markers; Wu, A.H.B., Eds.; Humana Press: Totowa, NJ, 1998; 205-227.
4. Collinson, P.O. Troponin T or troponin I or CK-MB (or none?). Eur. Heart J. 1998, 19 (supp N), N16-N24.
5. Li, D.; Keffer, J.; Corry, K.; Vazquez, M.; Jialal, I. Non-specific elevation of troponin T levels in patients with chronic renal failure. Clin. Biochem. 1995, 28, 474-477.
6. Frankel, W.L.; Herold, D.A.; Ziegler, T.W.; Fitzgerald, R.L. Cardiac troponin T is elevated in asymptomatic patients with chronic renal failure. Am. J. Clin. Pathol. 1996, 106, 118-123.
7. Kirvan, K.; Ryan, L.; Holleman, C.; Williamson, E.; Sedor, F. Troponin I and Troponin T in dialysis treated chronic renal failure - a 1 year follow-up. Clin. Chem. 1998, 44, A133.
8. Apple, F.S.; Sharkey, S.W.; Hoeft, P.; Skeate, R.; Voss, E.; Dahlmeier, B.A.; Presse, L.M. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcomes analysis. Am. J. Kidney Dis. 1997, 29, 399-403.
9. McLaurin, M.D.; Apple, F.S.; Voss, E.M.; Herzog, C.A.; Sharkey, S.W. Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. Clin. Chem. 1997, 43, 976-982.
10. Haller, C.; Zehelein, J.; Remppis, A.; Muller-Bardorff, M.; Katus, H.A. Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle. Clin. Chem. 1998, 44, 930-938.
11. Ricchiuti, V.; Voss, E.M.; Ney, A.; Odland, M.; Anderson, P.A.W.; Apple, F.S. Cardiac troponin T isoforms expressed in renal disease skeletal muscle will not cause false-positive results with the second generation cardiac troponin T assay by Boehringer Mannheim. Clin. Chem. 1998, 44, 1919-1924.
12. Le, A.; Wilson, R.; Douek, K.; Pulliam, R.; Tolzman, D.; Norman, D.; Bennett, W. Prospective risk stratification in renal transplant candidates for cardiac death. Am. J. Kidney Dis. 1994, 24, 65-71.
13. Wilson, R.A.; Norman, D.J.; Barry, J.M.; Bennett, W.M. Noninvasive cardiac testing in the end-stage renal disease patient. Blood Purif. 1994, 12, 78-83.
14. Gerson, M.C. Test accuracy, test selection and test result interpretation in chronic coronary artery disease. In Cardiac Nuclear Medicine; 2nd Ed.; Gerson, M.C., Ed.; McGraw-Hill: New York, 1987; 401-444.
15. Maddahi, J.; Kiat, H.; Van Train, K.F. Myocardial perfusion imaging with technetium -99 m sestamibi SPECT in the evaluation of coronary artery disease. Am. J. Cardiol. 1990, 66, 55E-62E.
16. Mueller-Bardoff, M.; Hallermayer, K.; Schroeder, A.; Ebert, C.; Borgya, A.; Gerhard, T.W.; Remppis, A.; Zehelein, J.; Katos, H.A. Improved troponin T ELISA specific for the cardiac troponin T isoform. Part 1: development, analytical and clinical validation of the assay. Clin. Chem. 1997, 43, 458-461.
17. Bialk, P.; Vogel, D.; Mayr, S.; Richter, S.; Franken, N. Electro-chemiluminescent immunoassay for troponin T using the random-access analyzer. Elecsys. Clin. Chem. 1995, 41, S60.
18. Porter, G.A.; Norton, T.; Bennett, W.B. Troponin T, a predictor of death in chronic hemodialysis patients. Eur. Heart J. 1998, 19 (supp N), N34-N37.
19. Bodor, G.S.; Porter, S.; Landt, Y.; Ladenson, J.H. Development of monoclonal antibodies for the assay of cardiac troponin I and preliminary results in suspected cases of myocardial infarction. Clin. Chem. 1992, 38, 2203-2214.
20. Tietz, N.W. Textbook of Clinical Chemistry; WB Saunders: Philadelphia, 1986; 684 pp.
21. Siegel, S.; Castellan, N.J., Jr. Nonparametric Statistics; 2nd Ed.; McGraw-Hill: New York, 1988.
22. De Lemos, J.A.; Hillis, L.D. Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis. J. Am. Soc. Nephrol. 1996, 7, 2044-2054.
23. VI Causes of Death. United States Renal Data System 1998 Annual Data Report. Am. J. Kidney Dis. 1998, 32 (suppl), S81-S88.
24. Lindner, A.; Charra, B.; Sherrard, D.J.; Scribner, B.H. Accelerated arteriosclerosis in prolonged maintenance hemodialysis. N. Engl. J. Med. 1974, 290, 697-701.
25. Weinrauch, L.; D'Elia, J.; Healy, R.; Gleason, R.; Christlieb, F.; Leland, O. Asymptomatic coronary artery disease: angiographic assessment of diabetics evaluated for renal transplantation. Circulation 1978, 58, 1184-1189.
26. Rostand, S.; Kirk, K.; Rutsky, E. The epidemiology of coronary artery disease in patients on maintenance hemodialysis: implication for management. Contrib. Nephrol. 1986, 52, 34-41.
27. Anasari, A.; Kaupke, C.; Vazirir, N.; Miller, R.; Barbari, A. Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis. Int. J. Artif. Organs 1993, 16, 31-36.
28. Rostand, S.; Kirk, K.; Rutsky, E. Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease. Kidney Int. 1982, 22, 304-308.
29. Vincenti, F.; Amend, W.; Abele, J.; Feduska, N.; Salvatierra, O. The role of hypertension in hemodialysis-associated atherosclerosis. Am. J. Med. 1980, 68, 363-369.
30. Bennett, W.M.; Kloster, F.; Rosch, J.; Barry, J.; Porter, G.A. Natural history of asymptomatic coronary arteriographic lesions in diabetic patients with end-stage renal disease. Am. J. Med. 1978, 65, 779-784.
31. Weinrauch, L.A.; D'Elia, J.A.; Healy, R.W.; Gleason, R.E.; Takacs, F.J.; Libertino, J.A.; Leland, O.S., Jr. Asymptomatic coronary artery disease: angiography in diabetic patients before renal transplant - relation of findings to postoperative survival. Ann. Intern. Med. 1978, 88, 346-348.
32. Jensen, T.; Borch-Johnsen, K.; Kofoed-Enevoldsen, A.; Deckert, T. Coronary artery disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 1987, 30, 144-148.
33. Krolewski, A.; Kosinski, E.; Warram, J. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am. J. Cardiol. 1987, 59, 750-755.
34. Wu, A.H.B.; Feng, Y.J. Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes. Eur. Heart J. 1998, 19, N25-N29.
35. Wu, A.H.B.; Feng, Y.J.; Moore, R.; Apple, F.S.; McPherson, P.H.; Buechler, K.F.; Bodor, G. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin. Chem. 1998, 44, 1198-1208.
36. Ooi, D.S.; House, A.A. Cardiac troponin T in hemodialysis patients. Clin. Chem. 1998, 44, 1410-1416.
37. Lowbeer, C.; Ottosson-Seeberger, A.; Gustafsson, S.A.; Norrman, R.; Hulting, J.; Gutierrez, A. Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease. Nephrol. Dial. Transplant. 1999, 14, 1948-1955.
38. Van Lente, F.; McErlean, E.S.; DeLuca, S.A.; Peacock, R.; Rao, J.S.; Nissen, S.E. Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study. J. Am. Coll. Cardiol. 1999, 33, 471-478.
39. Medeiros, L.J.; Schotte, D.; Gerson, B. Reliability and significance of increased creatine kinase MB isoenzyme in the serum of uremic patients. Am. J. Clin. Pathol. 1987, 87, 103-108.
40. Robbins, M.J.; Epstein, E.M.; Shah, S. Creatine kinase subform analysis in hemodialysis patients without acute coronary syndromes. Nephron 1997, 76, 296-299.
41. Tun, A.; Khan, I.A.; Win, M.T.; Hussain, A.; Hla, T.A.; Wattanasuwan, N.; Vasavada, B.C.; Sacchi, T.J. Specificity of cardiac troponin I and creatine kinase-MB isoenzyme in asymptomatic long-term hemodialysis patients and effect of hemodialysis on these cardiac markers. Cardiology 1998, 90, 280-285.